EBElhusseny Abdelawal Bossila

Elhusseny Abdelawal Bossila

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Elhusseny Abdelawal Bossila has a total of 14 co-authors. Here are the top co-authors by number of shared publications:

  • Yong Zhao

    State Key Laboratory of Biomembrane and Membrane Biotechnology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China

    2 shared publications
  • Aly Mohamed El Refy

    Biotechnology Department, Faculty of Agriculture, University of Al-Azhar, Cairo.Egypt

    1 shared publication
  • Chenxu Zhao

    State Key Laboratory of Membrane Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China

    1 shared publication
  • Dong Wei

    State Key Laboratory of Membrane Biology, Institute of Zoology, Chinese Academy of Sciences , Beijing

    1 shared publication
  • Han Guo

    State Key Laboratory of Membrane Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China

    1 shared publication
  • Huawen Xu

    State Key Laboratory of Membrane Biology, Institute of Zoology, Chinese Academy of Sciences , Beijing

    1 shared publication

Latest Publications

  • Open Access

    Comparative effectiveness of organic additives and antibiotics in enhancing meat quality and production performance of broiler chickens

    by Elhusseny Abdelawal Bossila

    This study aims to compare the effectiveness of commercially available Biofactor (BF) water additives and antibiotics (AB) such as Florfenicol, Neomycin sulfate (30.76%), Tylosin, and Enrofloxacin compared to the control group. During the Experimental Periods, the present study investigates a significant increase in the BF group in total Live Body weight (LBW) with 2057.00 gm/bird compared with 1896.28 and 1924.28 gm/bird in control and AB groups, respectively. Furthermore, there is a significant increase in carcass weight (CW) in the BF group with 1608.29 gm/bird compared with 1422.67 and 1526.29 gm/bird in the control and AB groups, respectively. Moreover, the feed intake and feed conversion ratio (FCR) was the best in BF group compared with the control and AB groups. Also, A higher effective intramuscular fat (IMF) content was observed in BF group meat than in the control and AB groups. The lightness (L*) value was significantly highest in BF meat than in control and AB meat. The present research indicates that adding BF additives to water is an alternative to using antibiotics to enhance the productive performance and meat quality in -Arbor Acres-broiler chicks.


  • Comparative Effectiveness of Organic Additives and Antibiotics in Enhancing Meat Quality and Production Performance of Broiler Chickens

    by Elhusseny Abdelawal Bossila, Aly Mohamed El Refy, Yousry Abd El Gaed Dowidar, Khaled Roushdy Mohamed

    This study aimed to compare the effectiveness of commercially available Biofactor (BF) water additives and antibiotics (AB) such as Florfenicol, Neomycin sulfate (30.76%), Tylosin, and Enrofloxacin compared to the control group. During the Experimental Periods, the present study investigates a significant increase in the BF group in total Live Body weight (LBW) with 2057.00 gm/bird compared with 1896.28 and 1924.28 gm/bird in control and AB groups, respectively. Furthermore, a significant increase in caracas weight (CW) in the BF group, with 1608.29 gm/bird compared with 1422.67 and 1526.29 gm/bird in the control and AB groups, respectively. Moreover, the feed intake and feed conversion ratio (FCR) was the best in BF group compared with the control and AB groups. Also, A higher effective intramuscular fat (IMF) content was observed in BF group meat than in the control and AB groups. The lightness (L*) value was significantly highest in BF meat than in control and AB meat. The present research indicates that adding BF additives to water is an alternative to using antibiotics to enhance the productive performance and meat quality in -Arbor Acres-broiler chicks.

  • FABP5 Deficiency Impaired Macrophage Inflammation by Regulating AMPK/NF-κB Signaling Pathway

    by Yangxiao Hou, Dong Wei, Elhusseny A Bossila, Zhaoqi Zhang, Sihong Li, Jiaming Bao, Huawen Xu, Lianfeng Zhang, Yong Zhao

    Fatty acid binding protein 5 (FABP5) is mainly involved in the uptake, transport, and metabolism of fatty acid in the cytoplasm, and its role in immune cells has been recognized in recent years. However, the role of FABP5 in macrophage inflammation and its underlying mechanisms were not fully addressed. In our study, the acute liver injury and sepsis mouse models were induced by i.p. injection of LPS and cecal contents, respectively. Oleic acid (0.6 g/kg) was injected four times by intragastric administration every week, and this lasted for 1 wk before the LPS or cecal content challenge. We found that myeloid-specific deletion of FABP5 mitigated LPS-induced acute liver injury with reduced mortality of mice, histological liver damage, alanine aminotransferase, and proinflammatory factor levels. Metabolic analysis showed that FABP5 deletion increased the intracellular unsaturated fatty acids, especially oleic acid, in LPS-induced macrophages. The addition of oleic acid also decreased LPS-stimulated macrophage inflammation in vitro and reduced acute liver injury in LPS-induced or cecal content–induced sepsis mice. RNA-sequencing and molecular mechanism studies showed that FABP5 deletion or oleic acid supplementation increased the AMP/ATP ratio and AMP-activated protein kinase (AMPK) activation and inhibited the NF-κB pathway during the inflammatory response to LPS stimulation of macrophages. Inhibiting AMPK activation or expression by chemical or genetic approaches significantly rescued the decreased NF-κB signaling pathway and inflammatory response in LPS-treated FABP5-knockout macrophages. Our present study indicated that inhibiting FABP5 or supplementation of oleic acid might be used for the treatment of sepsis-caused acute liver injury.


  • Open Access

    Dual Immune Regulatory Roles of Interleukin-33 in Pathological Conditions

    by Han Guo, Elhusseny A. Bossila, Xinran Ma, Chenxu Zhao, Yong Zhao

    Interleukin-33 (IL-33), a member of the IL-1 cytokine family and a multifunctional cytokine, plays critical roles in maintaining host homeostasis and in pathological conditions, such as allergy, infectious diseases, and cancer, by acting on multiple types of immune cells and promoting type 1 and 2 immune responses. IL-33 is rapidly released by immune and non-immune cells upon stimulation by stress, acting as an “alarmin” by binding to its receptor, suppression of tumorigenicity 2 (ST2), to trigger downstream signaling pathways and activate inflammatory and immune responses. It has been recognized that IL-33 displays dual-functioning immune regulatory effects in many diseases and has both pro- and anti-tumorigenic effects, likely depending on its primary target cells, IL-33/sST2 expression levels, cellular context, and the cytokine microenvironment. Herein, we summarize our current understanding of the biological functions of IL-33 and its roles in the pathogenesis of various conditions, including inflammatory and autoimmune diseases, infections, cancers, and cases of organ transplantation. We emphasize the nature of context-dependent dual immune regulatory functions of IL-33 in many cells and diseases and review systemic studies to understand the distinct roles of IL-33 in different cells, which is essential to the development of more effective diagnoses and therapeutic approaches for IL-33-related diseases.